CATALIS Québec is a non-profit organization whose governance relies on a network of public and private partners to carry out its mission and vision of operational improvement and excellence in clinical research in Quebec. The Advisory Committee plays an advisory role by supporting the executive management team in implementing the strategic plan and any priority actions approved by the board of directors.
Cinzia Raponi CPA, CMA
Research Institute McGill University Health Centre (MUHC)
Senior Manager – Acting Clinical Research
Sylvie Cossette CPA, CA
Associate Director of Research
Annie Morin PhD
Acting Assistant to the Scientific Director, Research Center
CHUS (CRCHUS) CIUSSS of Estrie – CHUS
Stéphane Bolduc MD FRCSC
Deputy-Director of clinical research
CHU de Québec – Université Laval
Pascale Landry PhD
Senior Clinical Research Associate, Clinical Research, Global Medical Division
Director, Site Relationship Partner
Director, Clinic Center Relationship Partner
Therapeutic Area Leader, Merck
Head of Country Trial Operations
Team Leader, Clinical Operations
David Senac Eng.
Project Manager, Interventional Studies
Hoffmann-La Roche Limited (Roche Canada)
Isabelle Voccia Ph.D
Therapeutic Area Specialist – Oncology and Immunology
Clinical Trial Portfolio Manager
Jean-François Leger M.Sc.
Site Partnership Manager, Sanofi Canada
Yvon Fréchette Chemist, M.Sc.
Innovation Advisor, Collaborative Research Direction
Ministry of the Economy and Innovation of Quebec
Jenny Kaeding Ph.D
Ethics Advisor, Research and Internal Coordination Division
Ministry of Health and Social Services
President and CEO
Scientific Advisory Committee
Dr. Angela Genge Chair
Neurologist and Director, Clinical Research Unit
Montreal Neurological Institute and Hospital
Dr. John Mitchell
Research Institute of the McGill University Health Centre (RI-MUHC)
Dr. Rahima Jamal
Hemato-oncologist and Director of the Unit for Innovative Therapies
University of Montreal Hospital Research Centre (CRCHUM)
Dr. Michael Sebag
Hematologist, Research Institute
McGill University Health Centre (RI-MUHC)
Dr. Maxime Chénard-Poirier
Hematologist and Oncologis
CHU de Québec-Université Laval Research Center
Dr. Jean-Claude Tardif
Montreal Heart Institute Research Center
Scientific Director, Montreal Health Innovations Coordinating Centre (MHICC)
Dr. Jean-Philippe Lafrance
Maisonneuve-Rosemont Hospital Research Centre
Associate Professor, Department of Pharmacology and Physiology Université de Montréal
Dr. Michel Duval
Head of the Hematology-Oncology Department and clinical researcher
CHU Sainte-Justine Research Center
Dr. Wilson H. Miller
Director, Clinical Research Unit
Jewish General Hospital, Lady Davis Institute for Medical Research
Dr. André Carpentier
Director of the Diabetes, Obesity and Cardiovascular Complications Research Axis
Centre for Research at the CHUS (CRCHUS) – Université de Sherbrooke
Patient Advisory Committee
Information and Support Coordinator
PROCURE – The Force Against Prostate Cancer
Vice President, Programs and Services
Muscular Dystrophy Canada
The ALS Society of Quebec
Director, Programs & Services and Government Relations
Multiple Sclerosis Society of Canada
President and CEO
Francine Forget Marin
Director, Health promotion and Research
The Heart & Stroke Foundation
Regroupement Québécois des Maladies Orphelines
Director, Patient Programs, Health Policy & Advocacy
Colorectal Cancer Canada
Quebec Cancer Coalition
Chief Scientific Officer
Cystic Fibrosis Canada
Director, public and patient engagement
Project Manager, Investments and Health Promotion
Quebec Breast Cancer Foundation
Ataxia Charlevoix-Saguenay Foundation
François Laviolette *
* François Laviolette was a true pillar of artificial intelligence research. In addition to his great passion and leadership in the field of data, he wished to give back by sharing his knowledge and vast experience until the last moment. Shortly before his passing, François had generously accepted to join the CATALIS-Clinical Research Quebec Patient Advisory Committee as the very first patient partner. In just a few months, François brought light and wisdom to the valorization of health research data and his work will continue to inspire our community. Our thoughts are with François’ family, colleagues and loved ones to whom we offer our deepest condolences.
Ethic Advisory Committee
Marie Hirtle LL.B., LL.M.,
President MUHC REB
Executive Assistant, DQEPE (Department of Quality, Evaluation, Performance and Ethics)
Me Brigitte Pâquet
Vice-President, REB MUHC
Assistant Director, Neuroethics Program
Me Marie-Josée Bernardi, Lawyer
President, Research Ethics Board
Head of the Office of Research Ethics
Annabelle Cumyn, MD, CM, MHPE
President, CIUSSS de l’Estrie-CHUS Research Ethics Board
Associate Professor, Department of Medicine, FMSS
Vanessa Chenel, PhD
Senior Ethics Advisor
President, Research Ethics Board
Department of Quality, Evaluation, Performance and Ethics
CIUSSS de l’Est-de-l’Île-de-Montréal
Me Geneviève Cardinal
President of the Research Ethics Committee
Head of the Research Ethics Office
President of the REB at the CHU de Québec
PhD, Coordinator of the Research Ethics Board of the CISSS du Bas-Saint-Laurent
Danika Laberge PMP
President and CEO of CATALIS Québec
Ms. Laberge has over 25 years of professional experience in the research sector and the health and social services network. Drawing on her expertise, operational excellence-oriented approach, leadership, and management skills, she created a vast network of partners (“The CATALIS Network”), which she consults on an ongoing basis to identify issues within the province’s clinical research industry and develop effective communal solutions serving to accelerate the launch and optimize the conduct of clinical trials. Most notable of Ms. Laberge’s major accomplishments is the harmonization, with the participation of the CATALIS Network, of clinical research administrative practices, which led to the creation of the FAST TRACK evaluation service. This innovative program makes it possible to evaluate and authorize clinical trials in Quebec in less than eight weeks.
Before joining CATALIS, Ms. Laberge spearheaded numerous projects, including the launch of CARTaGENE, a Quebec biobank. She also oversaw the implementation and management of the McGill University Health Centre Research Institute’s McConnell Centre for Innovative Medical.
Paul Lohnes CPA, CA
Director Finance and Administration of CATALIS Québec
Paul Lohnes is a senior executive with over 40 years of experience in professional services organizations in Canada. His credentials include: audit and professional practice as a partner with KPMG in Montreal and The Netherlands; senior roles in audit standard-setting and audit regulation and quality control; and chief executive of a not-for-profit organization in the public sector. In addition to financial and audit acumen, he brings to CATALIS expertise in governance and human resources management. Paul has a keen interest in healthcare research and in contributing to achieving CATALIS’ mission. He is currently a member of the Board and the Audit and Infrastructure Committee of the Montréal West Island Integrated University Health and Social Services Centre, a member of the executive committee of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis Research Network (ICanCME), and a member of the Board of NOVA Hudson.
Director, public and patient engagement of CATALIS Québec
With over ten years of professional experience in the general and operational management of health organizations, Olivier Jérôme has overseen various mandates that focused on patients and their family caregivers. A seasoned administrator in the organizational development and operationalization of health programs, he has actively participated in creating, reorganizing, and expanding the units he was responsible for, including those in reproductive medicine, obstetrics, oncology, and rare diseases. Olivier also has a comprehensive understanding of the political environment and governmental affairs in health at the federal and provincial levels. He will use this expertise to benefit patients and family caregivers by facilitating and accelerating access to innovative health treatments. He joins the CATALIS team with a passion for both research and access to innovation in health care and will undoubtedly contribute to the success of its mission.
Project Manager – CATALIS Québec
With more than fifteen years of experience in internationally renowned Quebec institutes and research centers, Maria has led numerous phase II to IV clinical trials in various therapeutic fields and has extensive operational expertise more specifically in the processes related to feasibility, budget development and negotiation, and submissions for the triple review, namely science, ethics and institutional conformity. Supported by extensive knowledge of ICH GCP guidelines, Health Canada regulations and ministerial standards, she specializes in the development and support of clinical research activities, as well as coordination with the various key players to achieve clinical research targets and maximum performance.
As Project Manager, Maria will be responsible for the implementation of the new FAST TRACK review service. She will have the pleasure of working and supporting a network of committed and dedicated members who are all devoted to optimizing and accelerating the accessibility of clinical trials in Quebec.
Head of Communications – CATALIS Québec
Isabelle began her career as a science journalist, a role that allowed her to cover topics such as neurodevelopmental disorders affecting Canadian children and stem cell transplants for the treatment of cancer. A quadrilingual communications professional specialized in digital marketing, she is passionate about health and innovation; she was the project manager of the award-winning injury prevention program at the McGill University Health Centre. Isabelle has led national and international marketing communications initiatives in Canada and abroad in areas ranging from healthcare reform to the reduction of maternal and neonatal mortality, namely in collaboration with the University of Montreal Hospital Centre.
A brand builder and a seasoned strategist, Isabelle looks forward to joining the CATALIS team to elevate the organization’s profile and promote Quebec’s expertise in clinical research, and ultimately participate in the acceleration of innovative treatments.
Patient and Clinician Support Service Coordinator – CATALIS Quebec
Maryse Patenaude holds a Master of Genetic Counseling from the Université de Montréal and a Specialized Studies Diploma in Management from HEC Montreal. She has been working in the health field for almost twenty years. Having acquired experience in clinical research with the Breast Cancer Research Group (Groupe de recherche en cancer du sein), Maryse then worked as a genetic counselor for over 10 years. She was able to share her knowledge of medical genetics with many patients and health professionals, mainly in the fields of prenatal genetics, reproduction, and oncology. Maryse then participated in the coordination and management of a research unit in the field of medical data analysis and integration, while ensuring the utmost respect for patient confidentiality, as well as for current standards and regulations.
Having developed an empathetic, patient-oriented approach, and with her vast experience in the Quebec health sector, Maryse is enthusiastically joining the CATALIS team to participate in the development of the personalized clinical trial support service.
Project Manager – CATALIS Quebec
Alexandra brings close to 10 years of experience in the field of clinical research. During that time, she has led several Phase I to IV clinical trials, both industry and investigator initiated. Having overseen the continuous ethics review for the Office of Responsible Conduct in Research at the Université de Montréal and having been a member of the CHU Sainte-Justine Research Ethics Board, she has built up an expertise in the fields of research ethics and the regulatory environment of clinical research in Quebec. This knowledge was put into use and refined when she coordinated all clinical research, at the macro level, of a hospitalization unit at the CHU Sainte-Justine.
As Project Manager at CATALIS, Alexandra will be responsible, in collaboration with the other project managers, for the implementation of the new FASTTRACK evaluation service. She will have the pleasure of working with and supporting a network of committed and dedicated members who are all eager to optimize and accelerate the accessibility of clinical trials in Quebec.
Project Manager – CATALIS Quebec
Natalie holds a BSc in Neuroscience and a MSc in Occupational Therapy, both from McGill University. Upon completing her Master’s degree she worked as a clinical research coordinator for several international phase 1-3 ALS studies at the Montreal Neurological Institute and Hospital, a top enrolling site. Natalie has extensive knowledge in neuromuscular diseases, good clinical practice, and clinical outcome measures. Before joining CATALIS, Natalie mentored a team of clinical research coordinators in ALS, overseeing approximately 15 trials at a time, while also partaking in start-up activities for new ALS studies.
Passionate about patient care and education, Natalie has participated in ALS support groups, educated newly diagnosed patients about clinical research, and contributed to clinical management research studies. She has attended and presented at national and international conferences for ALS, networking with researchers and sponsors around the world.As a Project Manager, Natalie will partake in the FAST TRACK program with the goal of helping patients obtain better access to clinical trials in Quebec.